Please login to the form below
Innovate UK appoints director for health and life sciences
Ian Campbell takes up the newly-created post
Innovate UK has appointed its first director for health and life sciences, with Ian Campbell taking up the role in Autumn 2016.
In his new position, Campbell will drive the development and delivery of the UK government-sponsored agency's life sciences and health sector.
Campbell currently serves as chief executive officer of Arquer Diagnostics, a UK based diagnostics company specialising in non-invasive tests for the detection of cancer.
Previously, he was commercial director for Bespak Europe, a medical devices manufacturer, and has served as the chief executive officer of Imperial College spin-out company Molecular Vision, which was acquired by Abingdon Health in 2012.
Dr Ruth McKernan, chief executive of Innovate UK, said: “Ian Campbell will make a strong addition to the team at Innovate UK.
“He has extensive entrepreneurial and business experience which make him well-suited to lead our health and life sciences team as we set out our strategy for supporting innovation and growth over the next five years.”
Subscribe to our email news alerts
- Pfizer’s RSV vaccine granted MHRA approval to protect infants and older adults
- Novavax’s updated COVID-19 vaccine granted Emergency Use Listing by WHO
- FDA to investigate risk of T-cell malignancy from CAR-T cell immunotherapies
- Boehringer Ingelheim and IBM announce AI antibody drug discovery partnership
- New blood test to reduce heart attacks and death rates in A&E heart patients
- Clairvoyant commercialisation
No results were found
PMHub
Say Communications
We focus on what matters most…. Driven by insight, expertise and fresh thinking, our award-winning communications programmes are designed to...
Latest intelligence
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
- The rise of digital healthcare – fuelled by open innovation in healthtech hubs
- How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...
